Rêncio Bento Florêncio1, Luiza Gabriela de Araújo Fonseca1, Vivian Fernanda Dantas da Silva2, Íllia Nadinne Dantas Florentino Lima3, Lucien Peroni Gualdi4. 1. Mestrando do Programa de Ciências da Reabilitação da Faculdade de Ciências da Saúde do Trairí/Universidade Federal do Rio Grande do Norte - FACISA/UFRN, Santa Cruz, RN, Brazil. 2. Graduanda do Curso de Fisioterapia da Faculdade de Ciências da Saúde do Trairí/Universidade Federal do Rio Grande do Norte - FACISA/UFRN, Santa Cruz, RN, Brazil. 3. Docente da Faculdade de Ciências da Saúde do Trairí/Universidade Federal do Rio Grande do Norte - FACISA/UFRN, Santa Cruz, RN, Brazil. 4. Docente da Faculdade de Ciências da Saúde do Trairí/Universidade Federal do Rio Grande do Norte - FACISA/UFRN, Santa Cruz, RN, Brazil. lugualdi@hotmail.com.
Abstract
BACKGROUND: Diabetes mellitus (DM) is an important public health problem worldwide. In addition to the impairment in functionality, the large number of complications which lead to hospitalizations results in high treatment costs. The aim of this study was to analyze the incidence of hospitalizations, mortality rate and hospital costs, as well as to observe the temporal trend of hospitalizations and length of hospital stay due to DM between 2008 and 2019 in Brazil. METHODS: This is a longitudinal descriptive study in which all data regarding hospital admissions registered in the Brazilian system of Hospital Information of "Sistema Único de Saúde" (SIH/SUS; http://datasus.saude.gov.br ) due to DM (ICD-10) were included. Comparisons among the groups were performed by an unpaired Student's t-test, two-way ANOVA with a Tukey post hoc test (p < 0.05). RESULTS: An increased hospitalization of 1.83% due to DM was observed between 2008 and 2019 in Brazil. The Southeastern region had the highest incidence (34.6%) and mortality rate when compared to the other regions (p < 0.05). We also found that females were more likely to be hospitalized in comparison to males, without a statistically significant difference. Finally, a progressive increase of hospitalizations and mortality rate were observed according to age groups, as well as increased spending due to DM hospitalizations over the years. CONCLUSION: Hospitalizations due to DM in Brazil showed an expressive increase over the last 12 years, and there is a need for primary healthcare interventions to help reduce this situation.
BACKGROUND:Diabetes mellitus (DM) is an important public health problem worldwide. In addition to the impairment in functionality, the large number of complications which lead to hospitalizations results in high treatment costs. The aim of this study was to analyze the incidence of hospitalizations, mortality rate and hospital costs, as well as to observe the temporal trend of hospitalizations and length of hospital stay due to DM between 2008 and 2019 in Brazil. METHODS: This is a longitudinal descriptive study in which all data regarding hospital admissions registered in the Brazilian system of Hospital Information of "Sistema Único de Saúde" (SIH/SUS; http://datasus.saude.gov.br ) due to DM (ICD-10) were included. Comparisons among the groups were performed by an unpaired Student's t-test, two-way ANOVA with a Tukey post hoc test (p < 0.05). RESULTS: An increased hospitalization of 1.83% due to DM was observed between 2008 and 2019 in Brazil. The Southeastern region had the highest incidence (34.6%) and mortality rate when compared to the other regions (p < 0.05). We also found that females were more likely to be hospitalized in comparison to males, without a statistically significant difference. Finally, a progressive increase of hospitalizations and mortality rate were observed according to age groups, as well as increased spending due to DM hospitalizations over the years. CONCLUSION: Hospitalizations due to DM in Brazil showed an expressive increase over the last 12 years, and there is a need for primary healthcare interventions to help reduce this situation.
Entities:
Keywords:
Diabetes mellitus; Health services research; Hospital costs; Hospitalization
Authors: Maria Inês Schmidt; Bruce Bartholow Duncan; Gulnar Azevedo e Silva; Ana Maria Menezes; Carlos Augusto Monteiro; Sandhi Maria Barreto; Dora Chor; Paulo Rossi Menezes Journal: Lancet Date: 2011-05-09 Impact factor: 79.321
Authors: L Guariguata; D R Whiting; I Hambleton; J Beagley; U Linnenkamp; J E Shaw Journal: Diabetes Res Clin Pract Date: 2013-12-01 Impact factor: 5.602
Authors: David E Laaksonen; Leo Niskanen; Kari Punnonen; Kristiina Nyyssönen; Tomi-Pekka Tuomainen; Veli-Pekka Valkonen; Riitta Salonen; Jukka T Salonen Journal: Diabetes Care Date: 2004-05 Impact factor: 19.112
Authors: Miriam Longo; Giuseppe Bellastella; Maria Ida Maiorino; Juris J Meier; Katherine Esposito; Dario Giugliano Journal: Front Endocrinol (Lausanne) Date: 2019-02-18 Impact factor: 5.555
Authors: Gabriela H Telo; Felipe Vogt Cureau; Martina S de Souza; Thais S Andrade; Fabiana Copês; Beatriz D Schaan Journal: Diabetol Metab Syndr Date: 2016-09-07 Impact factor: 3.320